Menopausal osteoporosis: screening, prevention and treatment.
Singapore Med J
; 62(4): 159-166, 2021 Apr.
Article
in English
| MEDLINE | ID: covidwho-1326002
ABSTRACT
Screening for osteoporosis in women can be based on age and weight, using the Osteoporosis Screening Tool for Asians and assessment for other risk factors such as early menopause, Chinese ethnicity and other secondary factors. Based on the resulting risk profile, women can be triaged to dual-energy X-ray absorptiometry (DEXA) scanning for definite diagnosis of osteoporosis. Treatment should be considered in women with previous fragility fractures, DEXA-diagnosed osteoporosis and high risk of fracture. Exercise improves muscle function, can help prevent falls and has moderate effects on improvements in bone mass. Women should ensure adequate calcium intake and vitamin D. Menopausal hormone therapy (MHT) effectively prevents osteoporosis and fractures, and should be encouraged in those aged < 50 years. For women aged < 60 years, MHT or tibolone can be considered, especially if they have vasomotor or genitourinary symptoms. Risedronate or bisphosphonates may then be reserved for those aged over 60 years.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Osteoporosis
/
Osteoporosis, Postmenopausal
Type of study:
Diagnostic study
/
Prognostic study
Limits:
Female
/
Humans
Language:
English
Journal:
Singapore Med J
Year:
2021
Document Type:
Article
Affiliation country:
SMEDJ.2021036
Similar
MEDLINE
...
LILACS
LIS